Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.

about

Poly(ortho ester) nanoparticles targeted for chronic intraocular diseases: ocular safety and localization after intravitreal injection.Systems genetics identifies a role for Cacna2d1 regulation in elevated intraocular pressure and glaucoma susceptibility.

P2860

Q39826905-25024D5D-4864-404B-B264-C09533C3182C Q46975114-296DBE37-AC37-4BA0-8402-6A2F79178209

P2860

Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.

Item

http://www.wikidata.org/entity/Q41975515

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Novel endogenous glycan therap ...... modeling, and biodistribution.

@en

type

Item

label

Novel endogenous glycan therap ...... modeling, and biodistribution.

@en

prefLabel

Novel endogenous glycan therap ...... modeling, and biodistribution.

@en

P1476

Novel endogenous glycan therap ...... modeling, and biodistribution

@en

P2093

Dorababu Madhura

http://www.w3.org/2001/XMLSchema#string

Huiling Li

http://www.w3.org/2001/XMLSchema#string

Mallika Palamoor

http://www.w3.org/2001/XMLSchema#string

Monica M Jablonski

http://www.w3.org/2001/XMLSchema#string

Walter T Luchsinger de Obarrio

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics

Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)

New approaches and potential treatments for dry age-related macular degeneration

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

Prevalence of age-related macular degeneration in the United States

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

Lactose supports Muller cell protein expression patterns in the absence of the retinal pigment epithelium.

Müller cell response to laser-induced increase in intraocular pressure in rats.

Macular degeneration: recent advances and therapeutic opportunities.

Analysis of apoptosis by cytometry using TUNEL assay.

P2888

s12248-014-9563-1

P304

311-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12248-014-9563-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bernd Meibohm

Shankar Swaminathan

P577

2014-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259957093

http://www.w3.org/2001/XMLSchema#string

P6179

1033434536

http://www.w3.org/2001/XMLSchema#string

P698

24470212

http://www.w3.org/2001/XMLSchema#string

P932

3933590

http://www.w3.org/2001/XMLSchema#string

Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.

about

P2860

P2860

Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P932